225 related articles for article (PubMed ID: 22015396)
21. Breast cancer, stem cells and sex hormones. Part 3: the impact of the menopause and hormone replacement.
Eden JA
Maturitas; 2011 Feb; 68(2):129-36. PubMed ID: 21145188
[TBL] [Abstract][Full Text] [Related]
22. Postmenopausal breast cancer, androgens, and aromatase inhibitors.
Campagnoli C; Pasanisi P; Castellano I; Abbà C; Brucato T; Berrino F
Breast Cancer Res Treat; 2013 May; 139(1):1-11. PubMed ID: 23572296
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.
Pristauz G; Petru E; Stacher E; Geigl JB; Schwarzbraun T; Tsybrovskyy O; Winter R; Moinfar F
Histopathology; 2010 Dec; 57(6):877-84. PubMed ID: 21166701
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
25. Androgens and breast cancer in premenopausal women.
Secreto G; Toniolo P; Pisani P; Recchione C; Cavalleri A; Fariselli G; Totis A; Di Pietro S; Berrino F
Cancer Res; 1989 Jan; 49(2):471-6. PubMed ID: 2521298
[TBL] [Abstract][Full Text] [Related]
26. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women.
Hofling M; Löfgren L; von Schoultz E; Carlström K; Söderqvist G
Gynecol Endocrinol; 2008 Jul; 24(7):405-10. PubMed ID: 18645713
[TBL] [Abstract][Full Text] [Related]
27. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
28. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
30. A physiologic role for testosterone in limiting estrogenic stimulation of the breast.
Dimitrakakis C; Zhou J; Wang J; Belanger A; LaBrie F; Cheng C; Powell D; Bondy C
Menopause; 2003; 10(4):292-8. PubMed ID: 12851512
[TBL] [Abstract][Full Text] [Related]
31. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
[TBL] [Abstract][Full Text] [Related]
32. Androgens and menopause.
Shulman LP
Minerva Ginecol; 2009 Dec; 61(6):491-7. PubMed ID: 19942837
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.
Bitzer J; Kenemans P; Mueck AO;
Maturitas; 2008 Mar; 59(3):209-18. PubMed ID: 18343056
[TBL] [Abstract][Full Text] [Related]
34. [Female sex hormones increase the risk of breast cancer].
Vatten L
Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
[TBL] [Abstract][Full Text] [Related]
35. Testosterone and biological characteristics of breast cancers in postmenopausal women.
Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675
[TBL] [Abstract][Full Text] [Related]
36. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
37. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
39. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
40. Androgen replacement for women.
Basson R
Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
